Get Ready for the Once-Monthly Injectable HIV Med, Cabenuva
November 2020
Cabenuva (cabotegravir/rilpivirine) will be the first INJECTABLE antiretroviral for adults with HIV.
It's a complete two-med HIV regimen that is given MONTHLY...and seems to maintain viral load suppression similar to standard 3-drug oral DAILY regimens (Triumeq, etc).
Cabenuva contains one vial of the new integrase inhibitor cabotegravir...and one vial of the non-nucleoside inhibitor rilpivirine.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive